Giulia Pasello

5.1k citations
199 papers · 3.8k · 2 hit papers · h-index 28

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • COVID-19 and healthcare impacts
    • Lung Cancer Research Studies
    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 58
    • Occupational and environmental lung diseases 39
    • Lung Cancer Diagnosis and Treatment 38
    • Cancer Immunotherapy and Biomarkers 28
    • Lung Cancer Research Studies 25
    • COVID-19 and healthcare impacts 6

Giulia Pasello

179 papers receiving 3.7k citations

Giulia Pasello's Hit Papers

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study 2020 · 488 citations
4880+2+4Years since publication100200300400

Peers

Giulia Pasello
Comparison fields: 5 of 88
  • Oncology 1.3k
  • Pulmonary and Respiratory Medicine 1.7k
  • Cancer Research 242
  • Neurology 230
  • Infectious Diseases 163
Replace Didier Debieuvre with:
Didier Debieuvre France
Elizabeth Fabre France
Jozef Šufliarský Slovakia
Marjorie Glass Zauderer United States
Anna Bettini Italy
Michael Thomas Schweizer United States
Marco Filetti Italy
Ke‐Neng Chen China
Andrea Forschner Germany
Miso Kim South Korea
Giulia Pasello relative to Didier Debieuvre France Didier Debieuvre's profile →
Citations per field
00.5×2×4×6.4×
Didier Debieuvre · 1×
Citations per year

Countries citing papers authored by Giulia Pasello

Since Specialization
Citations

This map shows the geographic impact of Giulia Pasello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Pasello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Pasello more than expected).

Fields of papers citing papers by Giulia Pasello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Pasello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Pasello. The network helps show where Giulia Pasello may publish in the future.

Co-authors

The 25 scholars most cited alongside Giulia Pasello, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Giulia Pasello Line = papers co-authored together Giulia Pasello links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2019493
2
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Hit paper breakdown →
2020488
3 2019191
4 2017118
5 2020107
6 201895
7 201893
8 201985
9 202269
10 202168
11 201964
12 201358
13 201057
14 201148
15 202248
16 201846
17
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.
201045
18 202144
19 201542
20 201940

About Giulia Pasello

Giulia Pasello is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 199 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (58 papers), Occupational and environmental lung diseases (39 papers), Lung Cancer Diagnosis and Treatment (38 papers), Cancer Immunotherapy and Biomarkers (28 papers), Lung Cancer Research Studies (25 papers), Cancer Genomics and Diagnostics (10 papers), Myasthenia Gravis and Thymoma (9 papers) and COVID-19 and healthcare impacts (6 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.7k citations), Cancer Research (242 citations), Neurology (230 citations) and Infectious Diseases (163 citations). Giulia Pasello has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include PierFranco Conte, Laura Bonanno, Valentina Guarneri, Alberto Pavan, Adolfo Gino Favaretto, Ilaria Attili, Fiorella Calabrese, Loredana Urso, Stefano Frega and Alessandro Dal Maso. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Cancers, The Oncologist and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact